{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T14:10:03Z","timestamp":1739715003644,"version":"3.37.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Lymphoma and Myeloma"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.3816\/clm.2009.n.088","type":"journal-article","created":{"date-parts":[[2010,1,6]],"date-time":"2010-01-06T02:02:24Z","timestamp":1262743344000},"page":"449-454","source":"Crossref","is-referenced-by-count":3,"title":["Brazilian Experience Using High-Dose Sequential Chemotherapy Followed by Autologous Hematopoietic Stem Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma"],"prefix":"10.3816","volume":"9","author":[{"given":"Bruno K.L.","family":"Duarte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella","family":"Valente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afonso C.","family":"Vigorito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco J.P.","family":"Aranha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gislaine","family":"Oliveira-Duarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliana C.M.","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Lorand-Metze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katia B.","family":"Pagnano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcia","family":"Delamain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 F.","family":"Marques Junior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia R.","family":"Brandalise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1rcio","family":"Nucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmino A.","family":"De Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CLM.2009.n.088_bib1","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM199211193272102","article-title":"Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD","volume":"327","author":"Canellos","year":"1992","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2009.n.088_bib2","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1200\/JCO.1998.16.12.3810","article-title":"BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP\/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's Lymphoma Study Group","volume":"16","author":"Diehl","year":"1998","journal-title":"J Clin Oncol"},{"issue":"suppl 1","key":"10.3816\/CLM.2009.n.088_bib3","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/annonc\/13.S1.112","article-title":"Prognostic factors and treatment outcome in patients with primary progressive and relapsed Hodgkin's disease","volume":"13","author":"Josting","year":"2002","journal-title":"Ann Oncol"},{"key":"10.3816\/CLM.2009.n.088_bib4","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/0140-6736(93)92411-L","article-title":"Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI trial","volume":"341","author":"Linch","year":"1993","journal-title":"Lancet"},{"key":"10.3816\/CLM.2009.n.088_bib5","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/S0140-6736(02)08938-9","article-title":"Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haematopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomized trial","volume":"359","author":"Schmitz","year":"2002","journal-title":"Lancet"},{"key":"10.3816\/CLM.2009.n.088_bib6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00001622-200203000-00005","article-title":"Hematopoietic stem cell transplantation in Hodgkin disease","volume":"14","author":"Reece","year":"2002","journal-title":"Curr Opin Oncol"},{"key":"10.3816\/CLM.2009.n.088_bib7","doi-asserted-by":"crossref","first-page":"761","DOI":"10.7326\/0003-4819-90-5-761","article-title":"Prolonged disease free survival in Hodgkin's disease with MOPP reinduction after first relapse","volume":"90","author":"Fisher","year":"1979","journal-title":"Ann Intern Med"},{"key":"10.3816\/CLM.2009.n.088_bib8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/oxfordjournals.annonc.a057689","article-title":"Salvage chemotherapy in Hodgkin's disease. Results in patients relapsing more than twelve months after first complete remission","volume":"1","author":"Viviani","year":"1990","journal-title":"Ann Oncol"},{"issue":"suppl 1","key":"10.3816\/CLM.2009.n.088_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/annonc\/2.suppl_1.9","article-title":"Primary and salvage chemotherapy in advanced Hodgkin's disease: the Milan Cancer Institute experience","volume":"2","author":"Bonadonna","year":"1991","journal-title":"Ann Oncol"},{"key":"10.3816\/CLM.2009.n.088_bib10","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/oxfordjournals.annonc.a058393","article-title":"CAPE\/PALE salvage chemotherapy for Hodgkin's disease patients relapsing within 1 year of ChlVPP chemotherapy","volume":"4","author":"Fairey","year":"1993","journal-title":"Ann Oncol"},{"key":"10.3816\/CLM.2009.n.088_bib11","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1200\/JCO.1992.10.2.210","article-title":"Conventional dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure","volume":"10","author":"Longo","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2009.n.088_bib12","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1182\/blood.V73.8.2086.2086","article-title":"Treatment of progressive Hodgkin's disease with intensive chemoradiotherapy and autologous bone marrow transplantation","volume":"73","author":"Phillips","year":"1989","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.n.088_bib13","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1200\/JCO.1991.9.10.1871","article-title":"Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's disease","volume":"9","author":"Reece","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2009.n.088_bib14","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1182\/blood.V81.5.1137.1137","article-title":"The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight-year study of 155 patients","volume":"81","author":"Chopra","year":"1993","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.n.088_bib15","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1200\/JCO.1993.11.4.704","article-title":"High-dose etoposide and melphalan, and autologous bone marrow transplantation for patients with advanced Hodgkin's disease: Importance of disease status at transplant","volume":"11","author":"Crump","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2009.n.088_bib16","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/oxfordjournals.annonc.a058662","article-title":"High dose chemotherapy followed by autologous hematopoietic rescue in Hodgkin's disease: Long term follow-up in 128 patients","volume":"4","author":"Bierman","year":"1993","journal-title":"Ann Oncol"},{"key":"10.3816\/CLM.2009.n.088_bib17","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1200\/JCO.1993.11.12.2351","article-title":"One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: Value of pretransplant disease status for predicting outcome","volume":"11","author":"Rapoport","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2009.n.088_bib18","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1182\/blood.V85.5.1381.bloodjournal8551381","article-title":"High-dose chemotherapy with or without total body irradiation followed by autologous bone marrow and\/or peripheral blood stem cell Hodgkin's disease: Results in 85 patients with analysis of prognostic factors","volume":"85","author":"Nademanee","year":"1995","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.n.088_bib19","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1182\/blood.V97.3.616","article-title":"A 2-step comprehensive high-dose chemotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model","volume":"97","author":"Moskowitz","year":"2001","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.n.088_bib20","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/oxfordjournals.annonc.a058043","article-title":"Prolonged disease-free survival after highdose sequential chemo-radiotherapy and haematopoietic autologous transplantation in poor prognosis Hodgkin's disease","volume":"2","author":"Gianni","year":"1991","journal-title":"Ann Oncol"},{"key":"10.3816\/CLM.2009.n.088_bib21","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/oxfordjournals.annonc.a058399","article-title":"High-dose sequential chemo-radiotherapy with peripheral blood progenitor cell support for relapsed or refractory Hodgkin's disease -a 6-year update","volume":"4","author":"Gianni","year":"1993","journal-title":"Ann Oncol"},{"key":"10.3816\/CLM.2009.n.088_bib22","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/annonc\/mdi003","article-title":"Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin Lymphoma: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG)","volume":"16","author":"Josting","year":"2005","journal-title":"Ann Oncol"},{"key":"10.3816\/CLM.2009.n.088_bib23","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1080\/10428190600570958","article-title":"High dose sequential chemotherapy and autologous stem cell transplantation in patients with relapsed\/refractory lymphoma","volume":"47","author":"Oyan","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.3816\/CLM.2009.n.088_bib24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1590\/S0100-879X2002000100007","article-title":"High-dose cyclophosphamide followed by autologous peripheral blood progenitor cell transplantation improves the salvage treatment for persistent or sensitive relapsed malignant lymphoma","volume":"35","author":"Baldissera","year":"2002","journal-title":"Braz J Med Biol Res"},{"key":"10.3816\/CLM.2009.n.088_bib25","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1002\/cncr.11414","volume":"97","author":"Tarella","year":"2003","journal-title":"Cancer"},{"key":"10.3816\/CLM.2009.n.088_bib26","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observation","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.3816\/CLM.2009.n.088_bib27","first-page":"163","article-title":"Evaluation of survival data and two new rank order statistics arising in its consideration","volume":"50","author":"Mantel","year":"1966","journal-title":"Cancer Chemother Rep"},{"key":"10.3816\/CLM.2009.n.088_bib28","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc, B"},{"key":"10.3816\/CLM.2009.n.088_bib29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/sj.thj.6200013","article-title":"The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting \u2013 Arlie House, Virginia, November, 1997","volume":"1","author":"Harris","year":"2000","journal-title":"Hematol J"},{"key":"10.3816\/CLM.2009.n.088_bib30","first-page":"1860","article-title":"Report of the Committee of Hodgkin's Disease Staging Classification","volume":"31","author":"Carbone","year":"1971","journal-title":"Cancer Res"},{"key":"10.3816\/CLM.2009.n.088_bib31","first-page":"127","article-title":"Hodgkin's disease in Brazil: a clinic pathologic study","volume":"82","author":"De Souza","year":"1997","journal-title":"Haematologica"},{"key":"10.3816\/CLM.2009.n.088_bib32","first-page":"1227","article-title":"Expression of Epstein-Barr virus in classical Hodgkin's lymphomas in Brazilian adult patients","volume":"86","author":"Vassallo","year":"2001","journal-title":"Haematologica"},{"key":"10.3816\/CLM.2009.n.088_bib33","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1200\/JCO.2001.19.5.1395","article-title":"Autologous stem-cell transplantation for Hodgkin's disease: results and prognostic factors in 494 patients from the Grupo Espa\u00f1ol de Linfomas\/Transplante Aut\u00f3logo de M\u00e9dula Osea Spanish Cooperative Group","volume":"19","author":"Sureda","year":"2001","journal-title":"J Clin Oncol"},{"issue":"suppl 1","key":"10.3816\/CLM.2009.n.088_bib34","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/annonc\/13.S1.67","article-title":"Prognostic factors in Hodgkin's lymphoma","volume":"13","author":"Zander","year":"2002","journal-title":"Ann Oncol"},{"key":"10.3816\/CLM.2009.n.088_bib35","doi-asserted-by":"crossref","first-page":"7604","DOI":"10.1200\/JCO.2005.02.6310","article-title":"Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study","volume":"23","author":"Keegan","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2009.n.088_bib36","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/sj.bmt.1702796","article-title":"Autotransplants for Hodgkin's lymphoma in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR)","volume":"27","author":"Lazarus","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.3816\/CLM.2009.n.088_bib37","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3109\/10428190109097649","article-title":"Incidence of post transplant myelodysplasia\/acute leukemia in non-Hodgkin's lymphoma patients compared with Hodgkin's disease patients undergoing autologous transplantation following cyclophosphamide, carmustine, and etoposide (CBV)","volume":"40","author":"Wheeler","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"10.3816\/CLM.2009.n.088_bib38","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/sj.bmt.1702510","article-title":"Myelodysplasias and leukemias after autologous stem cell transplantation for lymphoid malignancies","volume":"26","author":"Park","year":"2000","journal-title":"Bone Marrow Transplant"}],"container-title":["Clinical Lymphoma and Myeloma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1557919011700373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1557919011700373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T13:41:17Z","timestamp":1739713277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1557919011700373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S1557919011700373"],"URL":"https:\/\/doi.org\/10.3816\/clm.2009.n.088","relation":{},"ISSN":["1557-9190"],"issn-type":[{"type":"print","value":"1557-9190"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}